The global narcolepsy drugs market size was valued at $2,680.06 million in 2020, and is projected to reach $6,667.80 million by 2030, registering a CAGR of 9.6% from 2021 to 2030. Narcolepsy is a chronic sleep disorder that affects the brain’s ability to control sleep-wake cycles. It is characterized by overwhelming daytime drowsiness and sudden attacks of sleep. People with narcolepsy often find it difficult to stay awake for long periods of time and feel very sleepy throughout much of the day.
Narcolepsy Drugs Market Highlights
- The increase in cases of narcolepsy is predicted to boost the growth of the industry over the estimated period.
- The ongoing advancements in the development of extended-release versions of sodium oxybate are expected to create wide opportunities in the market.
- The growing demand for narcolepsy drugs among individuals dealing with stress and pressure is expected to foster the market’s growth significantly.
Narcolepsy is a chronic disabling condition with symptoms such as cataplexy, excessive daytime sleepiness (EDS), sleep paralysis, hypnogogic hallucinations, and disrupted nocturnal sleep. Most of the narcolepsy drugs are used to treat symptoms related to cataplexy and excessive daytime sleepiness.
Narcolepsy Drugs Market Segment Overview
The Narcolepsy Drugs Market is segmented into disease type, therapeutic type, and region.
- Disease Type:Daytime extreme sleepiness is a prominent segment due to ongoing drug development efforts in this area.
- Therapeutic Type:Sodium oxybate is a major therapeutic type due to its widespread use in narcolepsy treatment.
- Regional Analysis:North America is expected to see the highest growth, partly due to increased R&D activities and unhealthy lifestyles.
Competitive Landscape:
- Bioprojet Pharma
- Takeda Pharmaceutical Company
- Arena Pharmaceutical
- Ligand Pharmaceuticals Inc
- Shinogi
- Teva Pharmaceutical Industries
- Novartis International
- Jazz Pharmaceutical
Key Benefits For Stakeholders
- This report provides a detailed quantitative analysis of the current narcolepsy drugs market trends and forecast estimations from 2020 to 2030, which assists to identify the prevailing narcolepsy drugs market opportunities.
- An in-depth market analysis includes analysis of various regions, which is anticipated to provide a detailed understanding of the current trends to enable stakeholders formulate region-specific plans.
- A comprehensive analysis of factors that drive and restrain the growth of the global is provided.
- The projections in this report are made by analyzing the current trends and future market potential from 2021 to 2030, in terms of value.
- An extensive analysis of various regions provides insights that are expected to allow companies to strategically plan their business moves.
- Key market players within the Narcolepsy drugs market are profiled in this report and their strategies are analyzed thoroughly, which helps in understanding competitive outlook of the Narcolepsy drugs market.
Read More:
Global Wearable Patch Market Surges with Rising Demand for Remote Health Monitoring
Hemodialysis Market to Reach US$ 111.8 Billion in 2032, Says Allied Market Research
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
